Another monoclonal antibody treatment, in this case, an antibody against amyloid beta.
This is excellent news, and should hopefully work. This is the same general treatment (monoclonal antibody treatment) that regeneron and bamlanivimab are for CoVI-2.
As these are targeted treatments, they will be far more efficacious at curing disease than non-targeted off label medications that may show a low level of efficacy. This is the current state of the art of medicine — and I am glad to see multiple applications of it.
Don’t get your hopes too high. In one trial the drug did not reach its desired endpoint. Amyloid plaque, as an Alzheimer’s cause, is a good theory, but there are others. Believe me, I hope there are effective treatments soon. My father passed away from Alzheimer’s and I’m now the same age he was when diagnosed.
Wow, been waiting and hoping for this news. My BIIB stocks have went up $120 per share or 43% today on this news. I hope it’s very successful, this disease is horrifying.